Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 |
|---|---|---|---|---|---|---|
| Revenue | 8.56B | 4.65B | 3.89B | 7.75B | 3.96B | 3.28B |
| Research and development | 840M | 836M | 843M | 707M | 716M | 704M |
| Selling, general and administrative | 409M | 401M | 422M | 394M | 389M | 394M |
| Operating expenses | 4.54B | 3.80B | 3.35B | 4.03B | 3.37B | 3.01B |
| Operating income | 4.02B | 855M | 534M | 3.72B | 593M | 271M |
| Interest expense | 70M | 58M | 58M | 68M | 60M | 60M |
| Pre-tax income | 4.05B | 869M | 561M | 3.68B | 571M | 213M |
| Income tax | 983M | 176M | 115M | 864M | 100M | 16M |
| Net income | 3.06B | 693M | 446M | 2.82B | 471M | 197M |
| Earnings per share | 11.10 | 2.49 | 1.60 | 10.09 | 1.68 | 0.70 |
| Earnings per share, diluted | 11.09 | 2.48 | 1.59 | 10.02 | 1.67 | 0.70 |
| Weighted average shares | 276M | 278M | 279M | 280M | 280M | 280M |
| Weighted average shares, diluted | 276M | 280M | 281M | 282M | 283M | 283M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 31 Jul 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 | 31 Jul 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 4.68B | 2.94B | 3.51B | 2.88B | 5.44B | 2.44B | 2.87B | 7.10B |
| Receivables | 834M | 1.18B | 579M |
| Metric | 30 Apr 2026 | 31 Jan 2026 | 31 Oct 2025 | 30 Apr 2025 | 31 Jan 2025 | 31 Oct 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | — | — | 637M | — | — | 362M |
| Depreciation and amortisation | — | — | 44M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 530M |
| 724M |
| 1.02B |
| 426M |
| 457M |
| Current assets | 17.84B | 11.70B | 10.42B | 14.11B | 13.97B | 9.14B | 10.73B | 9.68B |
| Property, plant and equipment | 996M | 974M | 965M | 961M | 975M | 992M | 1.01B | 1.01B |
| Goodwill | 13.98B | 13.98B | 13.98B | 13.98B | 13.85B | 13.84B | 13.84B | 13.84B |
| Total assets | 39.33B | 34.28B | 33.19B | 36.96B | 36.59B | 31.68B | 33.19B | 32.13B |
| Current liabilities | 12.28B | 8.84B | 7.52B | 10.37B | 9.65B | 7.18B | 8.62B | 7.49B |
| Short-term debt | 750M | 749M | 749M | 0 | 500M | 500M | 499M | 499M |
| Long-term debt | 5.41B | 5.41B | 5.39B | 5.97B | 5.91B | 5.76B | 5.63B | 5.54B |
| Total liabilities | 18.70B | 15.23B | 13.87B | 17.25B | 16.47B | 13.73B | 15.06B | 13.70B |
| Equity | 20.63B | 19.06B | 19.32B | 19.71B | 20.13B | 17.95B | 18.14B | 18.44B |
| Shares outstanding | — | — | — | 279M | — | — | — | 280M |
| — |
| 44M |
| Share-based compensation | 485M | 521M | 543M | 469M | 498M | 511M |
| Capital expenditure | — | — | 38M | — | — | 33M |
| Investing cash flow | — | — | 1.20B | — | — | −188M |
| Dividends paid | — | — | 341M | — | — | 296M |
| Share buybacks | — | — | 854M | — | — | 557M |
| Financing cash flow | — | — | −4.37B | — | — | 761M |